On 21 December 2022, we filed a case in the High Court of Australia against Brendan Murphy, Secretary of the Department of Health to stop TGA’s provisional approval of Moderna for use of its product (Spikevax) in children aged six months to five years old in Australia.
You can read our application as filed in the High Court here.
As instructing solicitors for the case, Peter Fam of Maat’s Method and Katie Ashby-Koppens of PJ O’Brien & Associates have been working hard alongside former barrister and legal consultant for the applicants, Julian Gillespie, to bring this case forward to the High Court.
In Australia, only an applicant with “standing” can bring a case to court. This means that an applicant needs to have the legal authority to bring a case; they need to show that they have a “special interest” in the matter and that they are truly “a person aggrieved” by the decision that has been made.
We want to bring a case straight to the High Court with one primary argument:
An interest in preserving human life is the ultimate special interest, and our case must be allowed to proceed. Then, if the High Court agrees, the door will be open for us to present the evidence and data to show that the provisional approvals must immediately be halted in Australia.
“The High Court of Australia is now being called upon to protect our youngest from participating in an acknowledged and ongoing Phase III clinical trial, to receive experimental drugs involving unprecedented levels of reported adverse events, including deaths .. for a virus also acknowledged to pose no threat to our babies and toddlers,” said Gillespie.
You can read more about the case here.
Source – https://www.maatsmethod.com.au/post/high-court-filing-the-australian-babies-case